Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Horst

Showing results (161-170 of 221) with videos related to

Pageof 23
Sort By:
Oncogene|December 2, 2020
Correction: EGFR activity addiction facilitates anti-ERBB based combination treatment of squamous bladder cancerMichael Rose, Angela Maurer, Julia Wirtz, et al.
Gynecologic Oncology|June 23, 2022
Predictive biomarker for surgical outcome in patients with advanced primary high-grade serous ovarian cancer. Are we there yet? An analysis of the prospective biobank for ovarian cancerCarlotta Keunecke, Hagen Kulbe, Felix Dreher, et al.
Virchows Archiv : an International Journal of Pathology|June 26, 2021
Status quo of ALK testing in lung cancer: results of an EQA scheme based on in-situ hybridization, immunohistochemistry, and RNA/DNA sequencingPhilipp Jurmeister, Claudia Vollbrecht, Korinna Jöhrens, et al.
British Journal of Cancer|August 28, 2025
Primary tumor sidedness and negative hyperselection to modulate anti-EGFR-based maintenance strategies in patients with RAS wild-type metastatic colorectal cancer: individual patient data pooled analysis of two randomized clinical trialsAlexej Ballhausen, Federica Morano, Arndt Stahler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2021
Panitumumab Plus Fluorouracil and Folinic Acid Versus Fluorouracil and Folinic Acid Alone as Maintenance Therapy in <i>RAS</i> Wild-Type Metastatic Colorectal Cancer: The Randomized PANAMA Trial (AIO KRK 0212)Dominik Paul Modest, Meinolf Karthaus, Stefan Fruehauf, et al.
Cell Reports|March 2, 2022
IKKα Promotes Intestinal Tumorigenesis by Limiting Recruitment of M1-like Polarized Myeloid CellsSerkan I Göktuna, Ozge Canli, Julia Bollrath, et al.
Cell Reports|June 3, 2014
IKKα promotes intestinal tumorigenesis by limiting recruitment of M1-like polarized myeloid cellsSerkan I Göktuna, Ozge Canli, Julia Bollrath, et al.
Human Pathology|September 24, 2023
LRP1B-a prognostic marker in tubo-ovarian high-grade serous carcinomaSvenja Kolb, Inga Hoffmann, Nanna Monjé, et al.
Genome Medicine|March 1, 2022
DNA methylation reveals distinct cells of origin for pancreatic neuroendocrine carcinomas and pancreatic neuroendocrine tumorsTincy Simon, Pamela Riemer, Armin Jarosch, et al.
Science (New York, N.Y.)|June 20, 2020
Measles virus and rinderpest virus divergence dated to the sixth century BCEAriane Düx, Sebastian Lequime, Livia Victoria Patrono, et al.
Pageof 23

Showing results (161-170 of 221) with videos related to

Sort By:
Pageof 23
Oncogene|December 2, 2020
Correction: EGFR activity addiction facilitates anti-ERBB based combination treatment of squamous bladder cancerMichael Rose, Angela Maurer, Julia Wirtz, et al.
Gynecologic Oncology|June 23, 2022
Predictive biomarker for surgical outcome in patients with advanced primary high-grade serous ovarian cancer. Are we there yet? An analysis of the prospective biobank for ovarian cancerCarlotta Keunecke, Hagen Kulbe, Felix Dreher, et al.
Virchows Archiv : an International Journal of Pathology|June 26, 2021
Status quo of ALK testing in lung cancer: results of an EQA scheme based on in-situ hybridization, immunohistochemistry, and RNA/DNA sequencingPhilipp Jurmeister, Claudia Vollbrecht, Korinna Jöhrens, et al.
British Journal of Cancer|August 28, 2025
Primary tumor sidedness and negative hyperselection to modulate anti-EGFR-based maintenance strategies in patients with RAS wild-type metastatic colorectal cancer: individual patient data pooled analysis of two randomized clinical trialsAlexej Ballhausen, Federica Morano, Arndt Stahler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2021
Panitumumab Plus Fluorouracil and Folinic Acid Versus Fluorouracil and Folinic Acid Alone as Maintenance Therapy in <i>RAS</i> Wild-Type Metastatic Colorectal Cancer: The Randomized PANAMA Trial (AIO KRK 0212)Dominik Paul Modest, Meinolf Karthaus, Stefan Fruehauf, et al.
Cell Reports|March 2, 2022
IKKα Promotes Intestinal Tumorigenesis by Limiting Recruitment of M1-like Polarized Myeloid CellsSerkan I Göktuna, Ozge Canli, Julia Bollrath, et al.
Cell Reports|June 3, 2014
IKKα promotes intestinal tumorigenesis by limiting recruitment of M1-like polarized myeloid cellsSerkan I Göktuna, Ozge Canli, Julia Bollrath, et al.
Human Pathology|September 24, 2023
LRP1B-a prognostic marker in tubo-ovarian high-grade serous carcinomaSvenja Kolb, Inga Hoffmann, Nanna Monjé, et al.
Genome Medicine|March 1, 2022
DNA methylation reveals distinct cells of origin for pancreatic neuroendocrine carcinomas and pancreatic neuroendocrine tumorsTincy Simon, Pamela Riemer, Armin Jarosch, et al.
Science (New York, N.Y.)|June 20, 2020
Measles virus and rinderpest virus divergence dated to the sixth century BCEAriane Düx, Sebastian Lequime, Livia Victoria Patrono, et al.
Pageof 23